Fig. 4From: High expression of GMNN predicts malignant progression and poor prognosis in ACCA prognostic nomogram with clinical features, GMNN expression levels, and DEGs-based signature risk score was established for ACC. (A) The nomogram could superiorly predict 1-, 2-, and 3-, 5-year OS of ACC patients. (B–C) The calibration plots also demonstrate excellent agreement between prediction and observation for the 1- and 3-year OS probabilities of the TCGA ACC patients. DEG differentially expressed gene, ACC adrenocortical carcinoma, OS overall survivalBack to article page